3.76 USD
↘ 0.17 (4.29%)LIVE (AS OF 12:43 PM EDT)
Perspective Therapeutics, Inc.
CATXAMEX • USD
Market: OPEN
Open?$3.82
High?$3.86
Low?$3.69
Prev. Close?$3.85
Volume?444.8K
Avg. Volume?1.3M
VWAP?$3.75
Rel. Volume?0.34x
Bid / Ask
Bid?$3.69 × 100
Ask?$3.70 × 700
Spread?$0.01
Midpoint?$3.70
Valuation & Ratios
Market Cap?439.1M
Shares Out?114.0M
Float?62.0M
Float %?83.4%
P/E Ratio?N/A
P/B Ratio?1.26
EPS?-$0.97
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Employees
166
Market Cap
439.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2003-12-29
Address
2401 ELLIOTT AVENUE
SEATTLE, WA 98121
Phone: 206-676-0900
SEATTLE, WA 98121
Phone: 206-676-0900
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?8.75Strong
Quick Ratio?8.75Strong
Cash Ratio?1.71Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?1.26CHEAP▾
P/S?710.48HIGH▾
P/FCF?N/A▾
EV/EBITDA?-3.3CHEAP▾
EV/Sales?625.75HIGH▾
Returns & Efficiency
ROE?-32.0%WEAK▾
ROA?-27.1%WEAK▾
Cash Flow & Enterprise
FCF?$-107447000
Enterprise Value?$386.7M
Fundamentals ratios updated end of day